The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The Role of DNA Methylation in Cancer
Open accessAbstract
The malignant transformation of normal cells is driven by both genetic and epigenetic changes. With the advent of next-generation sequencing and large-scale multinational consortium studies, it has become possible to profile the genomes and epigenomes of thousands of primary tumors from nearly every cancer type. From these genome-wide studies, it became clear that the dynamic regulation of DNA methylation is a critical epigenetic mechanism of cancer initiation, maintenance, and progression. Proper control of DNA methylation is not only crucial for regulating gene transcription, but its broader consequences include maintaining the integrity of the genome and modulating immune response. Here, we describe the aberrant DNA methylation changes that take place in cancer and how they contribute to the disease phenotype. Further, we highlight potential clinical implications of these changes in the context of prognostic and diagnostic biomarkers, as well as therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · cited 2×
“The ENCODE project has surveyed a number of cell lines to extrapolate functional and regulatory elements of the genome, and the NIH Roadmap has focused its resources on interrogating various tissue types to identify tissue-specific regulation of the epigenome, while TCGA has comprehensively collected data from 10,000…”
BackgroundShrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 6×
“While DNMT1 carries out the majority of the DNA methylation in a dividing cell, DNMT3a/3b strongly associate with nucleosomes to permit efficient propagation of DNA methylation by modification of those sites missed by DNMT1 (Okano et al. 1999; Liang et al. 2002; Rhee et al. 2002; Jones and Liang 2009; Sharma et al. 20…”
BackgroundInfluentialFunctions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
The ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223 · cited 2×
“The ENCODE project has surveyed a number of cell lines to extrapolate functional and regulatory elements of the genome, and the NIH Roadmap has focused its resources on interrogating various tissue types to identify tissue-specific regulation of the epigenome, while TCGA has comprehensively collected data from 10,000…”
BackgroundThe Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Non-coding RNAs in human disease
Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129 · cited 2×
“islands are often, but not exclusively, found in the nearly half of all gene promoters (Mikkelsen et al. 2007; Meissner et al. 2008).”
BackgroundReview The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Tomczak, K., Czerwińska, P., & Wiznerowicz, M. (2015) · Współczesna Onkologia · doi:10.5114/wo.2014.47136 · Cited by 3,492
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485 · cited 2×
“Similarly, epigenetic silencing of tumor suppressor VHL via promoter methylation predisposes individuals to several malignancies including clear cell renal cell carcinoma (Herman et al. 1994; Esteller et al. 2000; Esteller 2001; Chiang et al. 2006; Creighton et al. 2013).”
BackgroundCpG Islands in vertebrate genomes
Gardiner-Garden, M., & Frommer, M. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90689-9 · Cited by 3,353
DNA methylation: roles in mammalian development
Smith, Z. D., & Meissner, A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3354 · Cited by 3,045 · cited 1×
“It is also involved in suppressing genes in a tissue-specific context and in facilitating allelic expression through genomic imprinting, and it is required for the inactivation of the additional copy of the X-chromosome in females (Smith and Meissner 2013).”
BackgroundA decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
Fenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70003-8 · Cited by 2,663
Sharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637
Genome-scale DNA methylation maps of pluripotent and differentiated cells
Meissner, A., Mikkelsen, T. S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., Zhang, X., Bernstein, B. E., Nusbaum, C., Jaffe, D. B., et al. (2008) · Nature · doi:10.1038/nature07107 · Cited by 2,536
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
The ENCODE (ENCyclopedia Of DNA Elements) Project
(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390
Cancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177
Chiappinelli, K. B., Strissel, P. L., Desrichard, A., Li, H., Henke, C., Akman, B., Hein, A., Rote, N. S., Cope, L. M., Snyder, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.011 · Cited by 2,022
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974 · cited 2×
“More recent studies have shown that the IDH1 mutation alone is sufficient to establish a hypermethylator phenotype in gliomas and that this hypermethylator status is retained in both early and late tumor of the same patient, suggesting that CIMP phenotype is an early event that is likely driving the tumorigenesis (Tur…”
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1993) · Nature · doi:10.1038/366362a0 · Cited by 1,964
The NIH Roadmap Epigenomics Mapping Consortium
Bernstein, B. E., Stamatoyannopoulos, J. A., Costello, J. F., Ren, B., Milosavljevic, A., Meissner, A., Kellis, M., Marra, M. A., Beaudet, A. L., Ecker, J. R., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1010-1045 · Cited by 1,892
The impact of retrotransposons on human genome evolution
Cordaux, R., & Batzer, M. A. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2640 · Cited by 1,703
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90228-3 · Cited by 1,691
TET enzymes, TDG and the dynamics of DNA demethylation
Kohli, R. M., & Zhang, Y. (2013) · Nature · doi:10.1038/nature12750 · Cited by 1,623 · cited 2×
“[PubMed: 21057493] Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation.”
BackgroundThe power and the promise of DNA methylation markers
Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562
Cytosine methylation and the ecology of intragenomic parasites
Yoder, J. A., Walsh, C. P., & Bestor, T. H. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01181-5 · Cited by 1,562
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Roulois, D., Loo Yau, H., Singhania, R., Wang, Y., Danesh, A., Shen, S. Y., Han, H., Liang, G., Jones, P. A., Pugh, T. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.056 · Cited by 1,527
Self-citationChristman, J. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205699 · Cited by 1,525
Modification of Enhancer Chromatin: What, How, and Why?
Calo, E., & Wysocka, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.038 · Cited by 1,457 · cited 1×
“DNA methylation can thwart the association of TF to DNA, and conversely, the presence of TFs can promote DNA hypomethylation by preventing DNMTs from accessing DNA (Calo and Wysocka 2013).”
BackgroundDNA methylation profiling of human chromosomes 6, 20 and 22
Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V. K., Attwood, J., Burger, M., Burton, J., Cox, T. V., Davies, R., Down, T. A., et al. (2006) · Nature Genetics · doi:10.1038/ng1909 · Cited by 1,348
Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
Self-citationPromoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Ko, M., Huang, Y., Jankowska, A. M., Pape, U. J., Tahiliani, M., Bandukwala, H. S., An, J., Lamperti, E. D., Koh, K. P., Ganetzky, R., et al. (2010) · Nature · doi:10.1038/nature09586 · Cited by 1,213
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Yang, X., Han, H., De Carvalho, D. D., Lay, F. D., Jones, P. A., & Liang, G. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.028 · Cited by 1,199 · cited 1×
“Thus, a potential mechanism of action for DNA methyltransferase inhibitors could be through mitigating the effect of deregulated c-MYC (Kasinathan and Henikoff 2014; Yang et al. 2014).”
BackgroundSelf-citationCancer Genetics and Epigenetics: Two Sides of the Same Coin?
You, J. S., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.06.008 · Cited by 1,167
Dna Hypomethylation In Cancer Cells
Ehrlich, M. (2009) · Epigenomics · doi:10.2217/epi.09.33 · Cited by 1,060
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., et al. (2002) · Nature · doi:10.1038/416552a · Cited by 1,039
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Stresemann, C., & Lyko, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23607 · Cited by 949
Interplay between the Cancer Genome and Epigenome
Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 910
TETonic shift: biological roles of TET proteins in DNA demethylation and transcription
Pastor, W. A., Aravind, L., & Rao, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3589 · Cited by 897 · cited 1×
“These enzymes, through successive enzymatic reactions, can oxidize 5- methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and 5-formylcytosine (5fC) to 5- carboxylcytosine (5caC) (Ko et al. 2010; Pastor et al. 2011, 2013).”
BackgroundThe 5-methylcytosine content of DNA from human tumors
Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., Oxenhandler, R., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.19.6883 · Cited by 844
Genomic imprinting: the emergence of an epigenetic paradigm
Ferguson-Smith, A. C. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3032 · Cited by 838
Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells
Pastor, W. A., Pape, U. J., Huang, Y., Henderson, H. R., Lister, R., Ko, M., McLoughlin, E. M., Brudno, Y., Mahapatra, S., Kapranov, P., et al. (2011) · Nature · doi:10.1038/nature10102 · Cited by 804 · cited 1×
“These enzymes, through successive enzymatic reactions, can oxidize 5- methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) and 5-formylcytosine (5fC) to 5- carboxylcytosine (5caC) (Ko et al. 2010; Pastor et al. 2011, 2013).”
BackgroundFunctional and Mechanistic Diversity of Distal Transcription Enhancers
Bulger, M., & Groudine, M. (2011) · Cell · doi:10.1016/j.cell.2011.01.024 · Cited by 803
Epigenetic modifications as therapeutic targets
Kelly, T. K., De Carvalho, D. D., & Jones, P. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1678 · Cited by 793
Rethinking how DNA methylation patterns are maintained
Jones, P. A., & Liang, G. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2651 · Cited by 765
Self-citationTsai, H.-C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F. V., Shin, J. J., Harbom, K. M., Beaty, R., Pappou, E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.029 · Cited by 650
The role of mutations in epigenetic regulators in myeloid malignancies
Shih, A. H., Abdel-Wahab, O., Patel, J. P., & Levine, R. L. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3343 · Cited by 611
Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Hinoue, T., Weisenberger, D. J., Lange, C. P. E., Shen, H., Byun, H.-M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M., et al. (2012) · Genome Research · doi:10.1101/gr.117523.110 · Cited by 601
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
Kulis, M., Heath, S., Bibikova, M., Queirós, A. C., Navarro, A., Clot, G., Martínez-Trillos, A., Castellano, G., Brun-Heath, I., Pinyol, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2443 · Cited by 578
Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements
Liang, G., Chan, M. F., Tomigahara, Y., Tsai, Y. C., Gonzales, F. A., Li, E., Laird, P. W., & Jones, P. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.480-491.2002 · Cited by 569
Self-citationThe activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., & Boon, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7149 · Cited by 542
Hypomethylation of ras oncogenes in primary human cancers
Feinberg, A. P., & Vogelstein, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80115-6 · Cited by 514
Cancer epigenomics: beyond genomics
Sandoval, J., & Esteller, M. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.02.008 · Cited by 474
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.
Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., & Dryja, T. P. (1991) · PubMed · Cited by 466
Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules
Kelly, T. K., Liu, Y., Lay, F. D., Liang, G., Berman, B. P., & Jones, P. A. (2012) · Genome Research · doi:10.1101/gr.143008.112 · Cited by 455 · cited 1×
“Although methylation of DNA has been noted to be inversely correlated with the presence of active histone marks, such as those that delineate active enhancers (Lay et al. 2015; Jones 2012; Kelly et al. 2012), expression-related methylation sites colocalizing with enhancers have also been observed.”
BackgroundSelf-citationCpG methylation is maintained in human cancer cells lacking DNMT1
Rhee, I., Jair, K.-W., Yen, R.-W. C., Lengauer, C., Herman, J. G., Kinzler, K. W., Vogelstein, B., Baylin, S. B., & Schuebel, K. E. (2000) · Nature · doi:10.1038/35010000 · Cited by 453
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
Esteller, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3001 · Cited by 441
Li, H., Chiappinelli, K. B., Guzzetta, A. A., Easwaran, H., Yen, R.-W. C., Vatapalli, R., Topper, M. J., Luo, J., Connolly, R. M., Azad, N. S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1782 · Cited by 430
Inheritance of a Cancer-Associated MLH1 Germ-Line Epimutation
Hitchins, M. P., Wong, J. J. L., Suthers, G., Suter, C. M., Martin, D. I. K., Hawkins, N. J., & Ward, R. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064522 · Cited by 418
Alterations of immune response of non-small cell lung cancer with Azacytidine
Wrangle, J., Wang, W., Koch, A., Easwaran, H., Mohammad, H. P., Pan, X., Vendetti, F., VanCriekinge, W., DeMeyer, T., Du, Z., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1542 · Cited by 386
DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes
Aran, D., Sabato, S., & Hellman, A. (2013) · Genome Biology · doi:10.1186/gb-2013-14-3-r21 · Cited by 341
Targeting DNA methylation for epigenetic therapy
Yang, X., Lay, F., Han, H., & Jones, P. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.001 · Cited by 326
Methylation profiling in acute myeloid leukemia
Toyota, M., Kopecky, K. J., Toyota, M.-O., Jair, K.-W., Willman, C. L., & Issa, J.-P. J. (2001) · Blood · doi:10.1182/blood.v97.9.2823 · Cited by 324
Preferential response of cancer cells to zebularine
Cheng, J. C., Yoo, C. B., Weisenberger, D. J., Chuang, J., Wozniak, C., Liang, G., Marquez, V. E., Greer, S., Orntoft, T. F., Thykjaer, T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.023 · Cited by 319
Self-citationAutophagy: a druggable process that is deregulated in aging and human disease
Kroemer, G. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78652 · Cited by 318
Wolff, E. M., Byun, H.-M., Han, H. F., Sharma, S., Nichols, P. W., Siegmund, K. D., Yang, A. S., Jones, P. A., & Liang, G. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000917 · Cited by 308
Self-citationAgirre, X., Vilas-Zornoza, A., Jiménez-Velasco, A., Martin-Subero, J. I., Cordeu, L., Gárate, L., San José-Eneriz, E., Abizanda, G., Rodríguez-Otero, P., Fortes, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4025 · Cited by 302
Yegnasubramanian, S., Haffner, M. C., Zhang, Y., Gurel, B., Cornish, T. C., Wu, Z., Irizarry, R. A., Morgan, J., Hicks, J., DeWeese, T. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6088 · Cited by 294
DNA Methylation Screening Identifies Driver Epigenetic Events of Cancer Cell Survival
De Carvalho, D. D., Sharma, S., You, J. S., Su, S.-F., Taberlay, P. C., Kelly, T. K., Yang, X., Liang, G., & Jones, P. A. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.045 · Cited by 285
Self-citationBreast Cancer Methylomes Establish an Epigenomic Foundation for Metastasis
Fang, F., Turcan, S., Rimner, A., Kaufman, A., Giri, D., Morris, L. G. T., Shen, R., Seshan, V., Mo, Q., Heguy, A., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001875 · Cited by 267
(1996) · PubMed · Cited by 242
Notes on the role of dynamic DNA methylation in mammalian development
Bestor, T. H., Edwards, J. R., & Boulard, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415301111 · Cited by 238
Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer
Kulis, M., Queirós, A. C., Beekman, R., & Martín-Subero, J. I. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.08.001 · Cited by 223
Delivery of 5-Aza-2′-Deoxycytidine to Cells Using Oligodeoxynucleotides
Yoo, C. B., Jeong, S., Egger, G., Liang, G., Phiasivongsa, P., Tang, C., Redkar, S., & Jones, P. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0251 · Cited by 219
Self-citationRole of Nucleosomal Occupancy in the Epigenetic Silencing of the MLH1 CpG Island
Lin, J. C., Jeong, S., Liang, G., Takai, D., Fatemi, M., Tsai, Y. C., Egger, G., Gal-Yam, E. N., & Jones, P. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.014 · Cited by 206
Self-citationCharacterizing DNA methylation alterations from The Cancer Genome Atlas
Weisenberger, D. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69740 · Cited by 200 · cited 1×
“…therefore, have been able to take advantage of the vast treasure trove of molecular data generated by these consortia to stratify cancer types into subgroups, gain insights into the mechanisms specific to these subgroups, and identify subgroup-specific therapeutic targets (Weisenberger 2014).”
BackgroundThe NIH Roadmap Epigenomics Program data Resource
Chadwick, L. H. (2012) · Epigenomics · doi:10.2217/epi.12.18 · Cited by 200
Lou, S., Lee, H.-M., Qin, H., Li, J.-W., Gao, Z., Liu, X., Chan, L. L., Lam, V., So, W.-Y., Wang, Y., et al. (2014) · Genome Biology · doi:10.1186/preaccept-1031081530108509 · Cited by 198
Donson, A. M., Addo‐Yobo, S. O., Handler, M. H., Gore, L., & Foreman, N. K. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20803 · Cited by 196
CHD5 , a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas
Fujita, T., Igarashi, J., Okawa, E. R., Gotoh, T., Manne, J., Kolla, V., Kim, J., Zhao, H., Pawel, B. R., London, W. B., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn176 · Cited by 188
Pessia, E., Makino, T., Bailly-Bechet, M., McLysaght, A., & Marais, G. A. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116763109 · Cited by 185
DNA Hypomethylation and Hemimethylation in Cancer
Ehrlich, M., & Lacey, M. R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9967-2_2 · Cited by 174
Ravenel, J. D., Broman, K. W., Perlman, E. J., Niemitz, E. L., Jayawardena, T. M., Bell, D. W., Haber, D. A., Uejima, H., & Feinberg, A. P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1698 · Cited by 172
Oki, Y., Aoki, E., & Issa, J.-P. J. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.010 · Cited by 172
Chuang, J. C., Warner, S. L., Vollmer, D. L., Vankayalapati, H., Redkar, S., Bearss, D. J., Qiu, X., Yoo, C. B., & Jones, P. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1048 · Cited by 170
DNA methylation as a universal biomarker
Levenson, V. V. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.17 · Cited by 166
PTEN Promoter Methylation in Sporadic Thyroid Carcinomas
Álvarez-Núñez, F., Bussaglia, E., Mauricio, D., Ybarra, J., Vilar, M., Lerma, E., de Leiva, A., & Matías‐Guiu, X. (2006) · Thyroid · doi:10.1089/thy.2006.16.17 · Cited by 164
p53 mutational spectra and the role of methylated CpG sequences
Pfeifer, G. P. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(00)00022-1 · Cited by 161
DNA Methylation of Transcriptional Enhancers and Cancer Predisposition
Aran, D., & Hellman, A. (2013) · Cell · doi:10.1016/j.cell.2013.06.018 · Cited by 161
Xist regulation and function eXplored
Pontier, D. B., & Gribnau, J. H. (2011) · Human Genetics · doi:10.1007/s00439-011-1008-7 · Cited by 156
Roles of Cell Division and Gene Transcription in the Methylation of CpG Islands
Bender, C. M., Gonzalgo, M. L., Gonzales, F. A., Nguyen, C. T., Robertson, K. D., & Jones, P. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6690 · Cited by 156
Taniguchi, T., Sullivan, M. J., Ogawa, O., & Reeve, A. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2159 · Cited by 141
Loss of Imprinting ofIGF2: A Common Epigenetic Modifier of Intestinal Tumor Risk
Kaneda, A., & Feinberg, A. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2959 · Cited by 135
O6-Methylguanine-DNA methyltransferase in glioma therapy: Promise and problems
Silber, J. R., Bobola, M. S., Blank, A., & Chamberlain, M. C. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.12.004 · Cited by 135
IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling
Lu, J., Song, G., Tang, Q., Zou, C., Han, F., Zhao, Z., Yong, B., Yin, J., Xu, H., Xie, X., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78437 · Cited by 134
BRCA1 promoter methylation predicts adverse ovarian cancer prognosis
Chiang, J. W., Karlan, B. Y., Cass, L., & Baldwin, R. L. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.10.034 · Cited by 134
Li, X., Yao, X., Wang, Y., Hu, F., Wang, F., Jiang, L., Liu, Y., Wang, D., Sun, G., & Zhao, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059064 · Cited by 127
The role of DNA methylation in directing the functional organization of the cancer epigenome
Lay, F. D., Liu, Y., Kelly, T. K., Witt, H. N., Farnham, P., Jones, P. A., & Berman, B. P. (2015) · Genome Research · doi:10.1101/gr.183368.114 · Cited by 123
Schmelz, K., Wagner, M., Dörken, B., & Tamm, I. (2004) · International Journal of Cancer · doi:10.1002/ijc.20797 · Cited by 121
Treppendahl, M. B., Qiu, X., Helbo, A. S., Yang, X., Nandrup-Bus, C., Hother, C. E., Andersen, M. K., Kjeldsen, L., Möllgaard, L., Hellström‐Lindberg, E., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362541 · Cited by 120
Self-citationSharma, S., De Carvalho, D. D., Jeong, S., Jones, P. A., & Liang, G. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001286 · Cited by 119
Self-citationEpigenetic Specificity of Loss of Imprinting of the IGF2 Gene in Wilms Tumors
Bjornsson, H. T., Brown, L. J., Fallin, M. D., Rongione, M. A., Bibikova, M. V., Wickham‐Garcia, E., Fan, J., & Feinberg, A. P. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm069 · Cited by 110
Su, S., Abreu, A. L., Chihara, Y., Tsai, Y., Andreu‐Vieyra, C., Daneshmand, S., Skinner, E. C., Jones, P. A., Siegmund, K. D., & Liang, G. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2637 · Cited by 105
Self-citationTreatment of Elderly Patients With Glioblastoma
Zarnett, O. J., Sahgal, A., Gosio, J., Perry, J., Berger, M. S., Chang, S. M., & Das, S. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3739 · Cited by 100
Søes, S., Daugaard, I., Sørensen, B. S., Carus, A., Mattheisen, M., Alsner, J., Overgaard, J., Hager, H., Hansen, L. L., & Kristensen, L. S. (2014) · Oncoscience · doi:10.18632/oncoscience.42 · Cited by 93
The Prognostic Value of Global DNA Hypomethylation in Cancer: A Meta-Analysis
Li, J., Huang, Q., Zeng, F., Li, W., He, Z., Chen, W., Zhu, W., & Zhang, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106290 · Cited by 87
Loss of Imprinting of IGF2 as an Epigenetic Marker for the Risk of Human Cancer
Cui, H. (2007) · Disease Markers · doi:10.1155/2007/363464 · Cited by 85
Srivastava, P., Paluch, B. E., Matsuzaki, J., James, S. R., Collamat, G., Taverna, P., Karpf, A. R., & Griffiths, E. A. (2015) · Epigenetics · doi:10.1080/15592294.2015.1017198 · Cited by 81
CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer
Ferreira, H. J., Heyn, H., Moutinho, C., & Esteller, M. (2012) · RNA Biology · doi:10.4161/rna.19353 · Cited by 80
Lee, K.-S., Park, J., Lee, K., Richardson, L. E., Johnson, B. H., Lee, H., Lee, J., Kim, S.-B., Kwon, O.-H., Song, K. S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2047 · Cited by 78
Saied, M. H., Marzec, J., Khalid, S., Smith, P., Down, T. A., Rakyan, V. K., Molloy, G., Raghavan, M., Debernardi, S., & Young, B. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033213 · Cited by 75
Epigenetic Therapy for Solid Tumors: from Bench Science to Clinical Trials
Juo, Y.-Y., Gong, X.-J., Mishra, A., Cui, X. X., Baylin, S. B., Azad, N. S., & Ahuja, N. (2015) · Epigenomics · doi:10.2217/epi.14.73 · Cited by 74
Exploiting epigenetic vulnerabilities for cancer therapeutics
Mair, B., Kubicek, S., & Nijman, S. M. B. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.01.001 · Cited by 73
DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension
Licht, J. D. (2015) · Cell · doi:10.1016/j.cell.2015.08.005 · Cited by 69
Recurrent epimutations activate gene body promoters in primary glioblastoma
Nagarajan, R. P., Zhang, B., Bell, R. J. A., Johnson, B., Olshen, A. B., Sundaram, V., Li, D., Graham, A. E., Diaz, A. A., Fouse, S. D., et al. (2014) · Genome Research · doi:10.1101/gr.164707.113 · Cited by 65
Fatemi, M., Paul, T. A., Brodeur, G. M., Shokrani, B., Brim, H., & Ashktorab, H. (2013) · Cancer · doi:10.1002/cncr.28316 · Cited by 58
Guadecitabine (SGI‐110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin
Kuang, Y., El-Khoueiry, A. B., Taverna, P., Ljungman, M. E., & Neamati, N. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.06.002 · Cited by 58
The Role of Gene Body Cytosine Modifications in MGMT Expression and Sensitivity to Temozolomide
Moen, E. L., Stark, A. L., Zhang, W., Dolan, M. E., & Godley, L. A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0924 · Cited by 55
The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinoma
Wang, J., Chen, H., Fu, S., Xu, Z., Sun, K.-L., & Fu, W. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.05.003 · Cited by 48
A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers
Vrba, L., Garbe, J. C., Stampfer, M. R., & Futscher, B. W. (2015) · Epigenetics · doi:10.1080/15592294.2015.1106673 · Cited by 37
Andreotti, G., Karami, S., Pfeiffer, R. M., Hurwitz, L. M., Liao, L. M., Weinstein, S. J., Albanes, D., Virtamo, J. R. K., Silverman, D. T., Rothman, N., et al. (2013) · Epigenetics · doi:10.4161/epi.27386 · Cited by 34
Epigenetic aspects of MDS and its molecular targeted therapy
Yamazaki, J., & Issa, J. J. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1197-4 · Cited by 29
Helbo, A. S., Treppendahl, M. B., Aslan, D., Dimopoulos, K., Nandrup-Bus, C., Holm, M., Andersen, M. K., Liang, G., Kristensen, L. S., & Grønbæk, K. (2015) · Genes · doi:10.3390/genes6040977 · Cited by 26
Self-citationDNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia
Božić, T., Lin, Q., Frobel, J., Wilop, S., Hoffmann, M., Müller‐Tidow, C., Brümmendorf, T. H., Jost, E., & Wagner, W. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0153-6 · Cited by 24
Hill, V. K., Shinawi, T., Ricketts, C. J., Krex, D., Schackert, G., Bauer, J., Wei, W., Cruickshank, G. S., Maher, E. R., & Latif, F. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-506 · Cited by 22
Contributions of DNA methylation aberrancies in shaping the cancer epigenome
Weisenberger, D. J., & Liang, G. (2015) · Translational Cancer Research · doi:10.21037/4482 · Cited by 21
Self-citation5-Aza-CdR Delivers a Gene Body Blow
Kasinathan, S., & Henikoff, S. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.004 · Cited by 11
Cited by
Lobo, J., Constâncio, V., Leite-Silva, P., Guimarães, R., Cantante, M., Braga, I., Maurício, J., Looijenga, L. H. J., Henrique, R., & Jerónimo, C. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01048-y · Cited by 28
Metadata
- Authors
- Lakshminarasimhan, R., & Liang, G.
- Venue
- Advances in Experimental Medicine and Biology
- Publisher
- Springer International Publishing
- Published
- 2016
- Volume
- 945
- Pages
- 151-172
- ISSN
- 0065-2598 (ISSN-L)
- 2214-8019
- OpenAlex
- W2549852019
- Cited by
- 259
- References
- 141
- FWCI
- 2.48
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.